Results supporting intralymphatic administration of Diamyd® published in the Journal of Diabetes Research

New results with the diabetes vaccine Diamyd®, comparing the immune responses after intralymphatic administration with immune responses after administering the vaccine subcutaneously, were published today in the Journal of Diabetes Research. The article, authored by researchers at Linköping University, describes that a more favorable immune response is achieved after intralymphatic treatment which may correlate with clinical effect. The results have generated patents filed by Diamyd Medical."These results are important as they support our strategy with intranodal treatment, and give a more